News

Prestige Brands launches Beano + Dairy Defense for those sensitive to certain dairy, grains, fruits and vegetables

BY Michael Johnsen

TARRYTOWN, N.Y. — Women know that dairy, whole grains, fruits and vegetables are keys to a balanced diet – yet many aren't eating them because of the uncomfortable consequences that often occur when they do. According to a recent national survey issued by Beano, the majority of women surveyed (75%) reported that many of these foods are out of the question for them because they can pose digestive issues, with nearly one-in-five respondents indicating it had been more than a month since they truly savored a meal without worry.
 
The reason? Painful gas, bloating, cramps, and diarrhea that can occur for millions of women when they eat these foods, severely limiting what they can consume. And, nearly half of women surveyed – 47% – agreed that they crave the freedom to not think about the potential consequences of certain foods before eating them.
 
New Beano + Dairy Defense is the first over-the-counter option that prevents both gas and dairy issues, giving women the freedom to eat the foods they want without worrying about the uncomfortable symptoms they can cause. It contains two natural enzymes that help the body break down potential "problem foods" such as vegetables, beans, whole grains and dairy, combining the gas prevention of Beano with a natural lactose aid for double protection. 
 
"We found that women are craving the ability to eat what they want without worrying about the consequences of digestive issues," stated Mary Beth Fritz, VP product innovation at Prestige Brands. "Beano Plus Dairy Defense is the first option that prevents both sets of symptoms, giving people the freedom to eat what they want, when they want, without the worry."
 
Every day, 70 million Americans suffer from some form of digestive issues. The majority of those surveyed indicated that many foods including vegetables, beans and whole grains were off-limits due to digestive issues (75%), and nearly half (46%) said that they frequently suffer from gas, pressure or bloating after consuming dairy products. This demonstrates that many more consumers actually suffer from digestive issues related to dairy (46%) than those that actually self-report lactose intolerance (19%). 
 
Among those surveyed, 42% reported taking nothing to treat their lactose symptoms, including gas pressure and bloating. Because the majority of these products are not intended to relieve gas or lactose sensitivity, most (77%) said they felt less than satisfied with the products available to treat or prevent both sets of symptoms. 
In fact, nearly two-thirds (61%) said they would be willing to try a new product that allowed them to relieve both symptoms and enabled them to eat more of the foods that they love.
 
The survey also revealed that the fear of experiencing gas and lactose intolerance symptoms frequently forces these women to change their behavior in social settings such as at work events (52%), parties (49%) or a restaurant (46%). 
 
The online consumer survey was conducted among a national sample of 829 women over the age of 55 who suffer from gas, 444 (54%) of whom also suffer from lactose intolerance or sensitivity. The survey was developed and sponsored by Beano + Dairy Defense, with fieldwork provided by Toluna Online using its national consumer panel.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Diplomat acquires MedPro Rx

BY Michael Johnsen

FLINT, Mich. — Diplomat on Thursday announced it has acquired MedPro Rx, a specialty pharmacy focused on specialty infusion therapies including hemophilia and immune globulin based in Raleigh, N.C.
  
"MedPro Rx shares our focus on caring for patients through personalized, high-touch service and communication," stated Phil Hagerman, Diplomat CEO. "We acquired MedPro to expand our existing specialty infusion business and to increase our presence in the mid-Atlantic and Southern regions of the country." 
 
"Diplomat's focus on providing consistent, high-touch patient care matches our own approach for MedPro Rx patients," commented Ron McFarlane, MedPro Rx COO. "We are pleased to know that the care of our patients will continue to meet the quality standards our patients know and rely on."
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

UrgentRx raises $17.5 million in capital, names former Adams Respiratory CEO chairman

BY DSN STAFF

DENVER — UrgentRx on Thursday announced that it has closed on $17.5 million of Series C growth capital. An undisclosed family office led the round along with participation from previous investors including Sam Zell, David Bonderman, Randall Kaplan/JUMP Investors and Boulevard Capital Management. The financing will be primarily used to support additional distribution opportunities as well as fund a national marketing campaign.
 
“Our goal at UrgentRx is to offer consumers the easiest and fastest solution for relief of whatever ails them, whenever and wherever it occurs,” stated Jordan Eisenberg, CEO UrgentRx. “UrgentRx Fast Powders are answering an unmet consumer need, providing the most convenient and fast relief available in the market. This infusion of capital gives us the resources to expand into new markets, launch innovative new products, and invest in national marketing to build increased awareness with consumers while supporting our retail partners.”
 
In conjunction with the capital raise, Michael Valentino, former CEO of Adams Respiratory Therapeutics, manufacturer of Mucinex and Delsym, will become chairman of the board. Valentino, a veteran of the OTC pharmaceutical industry, has been a member of the UrgentRx board of directors since July 2013. Under his leadership, Adams grew to over $450 million in annual revenue and was acquired by Reckitt Benckiser for approximately $2.3 billion in January 2008.
 
“There are few executives out there who have the track record and know our industry as well as Mike Valentino. I look forward to working even more closely with him as we continue to rapidly expand the UrgentRx brand,” Eisenberg said.
 
“As demonstrated by impressive retail acceptance and a rapid and efficient capital raise, UrgentRx is now ready and well-positioned to bring the consumer marketplace much-needed innovation for the OTC aisle,” Valentino said. “Today’s consumer tastes and preferences are always adjusting. More than ever before, their lifestyles require medications that can provide convenient, on-the-go relief. UrgentRx delivers on that promise better than anything else in the category.”
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES